Also trades as: 0KS6.L (LSE) · $vol 0M
PHM NYSE
PulteGroup, Inc.
1W: +8.4%
1M: -2.1%
3M: +5.0%
YTD: +13.2%
1Y: +16.2%
3Y: +75.8%
5Y: +169.6%
$134.75
+4.16 (+3.19%)
Weekly Expected Move ±4.8%
$117
$123
$129
$135
$141
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$26.0B
52W Range108.49-144.5
Volume1,627,770
Avg Volume1,829,890
Beta1.19
Dividend$1.00
Analyst Ratings
Company Info
CEORyan R. Marshall
Employees6,506
SectorConsumer Cyclical
IndustryResidential Construction
IPO Date1980-03-17
Websitepultegroupinc.com
3350 Peachtree Road NE
Atlanta, GA 30326
US
Atlanta, GA 30326
US
404 978 6400
About PulteGroup, Inc.
PulteGroup, Inc. engages in the homebuilding business. The firm is also involved in mortgage banking and title and insurance brokerage operations. It operates through the Homebuilding and Financial services business segments. The Homebuilding segment includes operations from Connecticut, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Virginia, Georgia, North Carolina, South Carolina, Tennessee, Florida, Illinois, Indiana, Kentucky, Michigan, Minnesota, Missouri, Ohio, Texas, Arizona, California, Nevada, New Mexico, and Washington. The Financial Services segment is composed of mortgage banking and title operations. The company was founded by William J. Pulte in 1950 and is headquartered in Atlanta, GA.
Latest News
Carrier Q2 Earnings & Sales Top Estimates, HVAC Orders Up Y/Y
Excedr raises $25 million in growth capital to expand its life sciences equipment leasing platform
Bank of Nova Scotia Cuts Stock Holdings in PulteGroup, Inc. $PHM
PulteGroup, Inc. (PHM) is Attracting Investor Attention: Here is What You Should Know
Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| HENRY KEVIN A | F-InKind | 2,093 | $126.02 | 2026-06-22 |
| Koart Matthew Willia | S-Sale | 7,457 | $120.00 | 2026-05-27 |
| Koart Matthew Willia | F-InKind | 6,861 | $111.77 | 2026-05-18 |
| Snyder Lila | S-Sale | 3,339 | $117.18 | 2026-05-08 |
| Schall Benjamin | A-Award | 1,507 | — | 2026-04-29 |